Trial intelligence / Profile preview

Intraoperative mannitol versus saline for delayed graft function prevention in kidney transplant recipients

IRCT20251231068512N1Phase 3Recruiting

Sponsor
Iran University of Medical Sciences
Start
Feb 2026
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial of Bronchitol in kidney failure (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Delayed graft function. Started Feb 2026; status: recruiting.

02

Drugs

Bronchitol
03

Conditions

kidney failure

Beyond the preview

Go deeper on IRCT20251231068512N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20251231068512N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call